Literature DB >> 11297676

Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'.

Michelle L L Donnelly1, Garry Luke1, Amit Mehrotra2, Xuejun Li1, Lorraine E Hughes1, David Gani2, Martin D Ryan1.   

Abstract

The 2A region of the aphthovirus foot-and-mouth disease virus (FMDV) polyprotein is only 18 aa long. A 'primary' intramolecular polyprotein processing event mediated by 2A occurs at its own C terminus. FMDV 2A activity was studied in artificial polyproteins in which sequences encoding reporter proteins flanked the 2A sequence such that a single, long, open reading frame was created. The self-processing properties of these artificial polyproteins were investigated and the co-translational 'cleavage' products quantified. The processing products from our artificial polyprotein systems showed a molar excess of 'cleavage' product N-terminal of 2A over the product C-terminal of 2A. A series of experiments was performed to characterize our in vitro translation systems. These experiments eliminated the translational or transcriptional properties of the in vitro systems as an explanation for this imbalance. In addition, the processing products derived from a control construct encoding the P1P2 region of the human rhinovirus polyprotein, known to be proteolytically processed, were quantified and found to be equimolar. Translation of a construct encoding green fluorescent protein (GFP), FMDV 2A and beta-glucuronidase, also in a single open reading frame, in the presence of puromycin, showed this antibiotic to be preferentially incorporated into the [GFP2A] translation product. We conclude that the discrete translation products from our artificial polyproteins are not produced by proteolysis. We propose that the FMDV 2A sequence, rather than representing a proteolytic element, modifies the activity of the ribosome to promote hydrolysis of the peptidyl(2A)-tRNA(Gly) ester linkage, thereby releasing the polypeptide from the translational complex, in a manner that allows the synthesis of a discrete downstream translation product to proceed. This process produces a ribosomal 'skip' from one codon to the next without the formation of a peptide bond.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297676     DOI: 10.1099/0022-1317-82-5-1013

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  290 in total

1.  RECODE 2003.

Authors:  Pavel V Baranov; Olga L Gurvich; Andrew W Hammer; Raymond F Gesteland; John F Atkins
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 2.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling.

Authors:  Joshua E Babiarz; Morgane Ravon; Sriram Sridhar; Palanikumar Ravindran; Brad Swanson; Hans Bitter; Thomas Weiser; Eric Chiao; Ulrich Certa; Kyle L Kolaja
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

4.  A novel approach for directing transgene expression in Drosophila: T2A-Gal4 in-frame fusion.

Authors:  Fengqiu Diao; Benjamin H White
Journal:  Genetics       Date:  2011-12-29       Impact factor: 4.562

5.  Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.

Authors:  Luke D Jasenosky; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

6.  Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.

Authors:  Tara G Edmonds; Haitao Ding; Xing Yuan; Qing Wei; Kendra S Smith; Joan A Conway; Lindsay Wieczorek; Bruce Brown; Victoria Polonis; John T West; David C Montefiori; John C Kappes; Christina Ochsenbauer
Journal:  Virology       Date:  2010-09-21       Impact factor: 3.616

7.  TEV protease-facilitated stoichiometric delivery of multiple genes using a single expression vector.

Authors:  Xi Chen; Elizabeth Pham; Kevin Truong
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

8.  Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.

Authors:  F Alaee; O Sugiyama; M S Virk; H Tang; H Drissi; A C Lichtler; J R Lieberman
Journal:  Gene Ther       Date:  2013-11-28       Impact factor: 5.250

9.  Molecular analysis of three Ljungan virus isolates reveals a new, close-to-root lineage of the Picornaviridae with a cluster of two unrelated 2A proteins.

Authors:  Susanne Johansson; Bo Niklasson; Jacob Maizel; Alexander E Gorbalenya; A Michael Lindberg
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Reversible optogenetic control of kinase activity during differentiation and embryonic development.

Authors:  Vishnu V Krishnamurthy; John S Khamo; Wenyan Mei; Aurora J Turgeon; Humza M Ashraf; Payel Mondal; Dil B Patel; Noah Risner; Ellen E Cho; Jing Yang; Kai Zhang
Journal:  Development       Date:  2016-10-03       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.